1. Piraccini BM, Alessandrini A. Androgenetic alopecia. G ItalDermatol Venereol. 2014 Feb;149(1):15-24. PMID: 24566563.
2. Психодерматологія. Медико-психологічні аспекти дії психосоціального стресу в клінічній і естетичній дерматологічнійпрактиці : колективна монографія за загальною редакцієюпроф. М. В. Маркової, д. мед. н. І. Р. Мухаровської. Харків : Друкарня «Мадрид», 2019. 277 с.
3. Dhami L. Psychology of Hair Loss Patients and Importanceof Counseling. Indian J Plast Surg. 2021 Dec 31;54(4):411-415.doi: 10.1055/s-0041-1741037.
4. Aldhouse NVJ, Kitchen H, Knight S, Macey J, Nunes FP,Dutronc Y, et al. “‘You lose your hair, what’s the big deal?’ I wasso embarrassed, I was so self-conscious, I was so depressed:”a qualitative interview study to understand the psychosocial burden of alopecia areata. J Patient Rep Outcomes. 2020Sep 11;4(1):76. doi: 10.1186/s41687-020-00240-7.
5. Aukerman E.L., Jafferany M. The psychological consequences of androgenetic alopecia: A systematic review //J Cosmet Dermatol. 2023. 22(1). 89-95. doi: 10.1111/jocd.14983.
6. Titeca G, Goudetsidis L, Francq B, Sampogna F, Gieler U,Tomas-Aragones L, et al. ‘The psychosocial burden of alopeciaareata and androgenetica’: a cross-sectional multicentre studyamong dermatological out-patients in 13 European countries.J Eur Acad Dermatol Venereol. 2020 Feb;34(2):406-411. doi:10.1111/jdv.15927. Erratum in: J Eur Acad Dermatol Venereol.2020 May;34(5):1119. doi: 10.1111/jdv.16298.
7. Huang C., Fu Y., Chi C. Health‐related quality of life, depression, and self‐esteem in patients with androgenetic alopecia:a systematic review and meta‐analysis. JAMA Dermatol. 2021Aug 1;157(8):963-970. doi: 10.1001/jamadermatol.2021.2196.
8. Zac RI, da Costa A. Patient satisfaction and quality of lifeamong adult women with androgenetic alopecia using 5 %topical minoxidil. J Clin Aesthet Dermatol. 2021 May;14(5):26-30. PMID: 34188746; PMCID: PMC8211325.
9. Mesinkovska N, King B, Mirmirani P, Ko J, Cassella J.Burden of illness in alopecia areata: a cross-sectional onlinesurvey study. J Investig Dermatol Symp Proc. 2020 Nov;20(1):S62-S68. doi: 10.1016/j.jisp.2020.05.007.
10. Marahatta S, Agrawal S, Adhikari BR. PsychologicalImpact of Alopecia Areata. Dermatol Res Pract. 2020Dec24;2020:8879343. doi: 10.1155/2020/8879343.
11. Torales J, Castaldelli-Maia JM, Ventriglio A, Almirón-Santacruz J, Barrios I, O’Higgins M, et al. Alopecia areata: A psychodermatological perspective. J Cosmet Dermatol. 2022Jun;21(6):2318-2323. doi: 10.1111/jocd.14416.
12. Toussi A, Barton VR, Le ST, Agbai ON, Kiuru M. Psychosocial and psychiatric comorbidities and health-related qualityof life in alopecia areata: a systematic review. J Am Acad Dermatol. 2021 Jul;85(1):162-175. doi: 10.1016/j.jaad.2020.06.047.
13. Tzur Bitan D, Berzin D, Kridin K, Cohen A. The association between alopecia areata and anxiety, depression,schizophrenia, and bipolar disorder: a population-based study. Arch Dermatol Res. 2022 Jul;314(5):463-468. doi: 10.1007/s00403-021-02247-6.
14. Macbeth AE, Holmes S, Harries M. Chiu WS, et al. The associated burden of mental health conditions in alopecia areata:a population-based study in UK primary care. British Journalof Dermatology. 2022;187:73–81. doi: 10.1111/bjd.21055.
15. Senna M, Ko J, Glashofer M, et al. Predictors of quality of life in patients with alopecia areata. J Invest Dermatol.2022. Oct;142(10):2646-2650.e3. doi: 10.1016/j.jid.2022.02.019.
16. Gelhorn HL, Cutts K, Edson-Heredia E, et al. The relationship between patient-reported severity of hair lossand health-related quality of life and treatment patternsamong patients with alopecia areata. Dermatol Ther. 2022Apr;12(4):989-997. doi: 10.1007/s13555-022-00702-4.
17. Mesinkovska N, Craiglow B, Ball SG, Morrow P, Smith SG,Pierce E, Shapiro J. The Invisible Impact of a Visible Disease: Psychosocial Impact of Alopecia Areata. Dermatol Ther (Heidelb).2023 Jul;13(7):1503-1515. doi: 10.1007/s13555-023-00941-z.
18. King BA, Senna MM, Ohyama M, Tosti A, Sinclair RD,Ball S, et al. Defining severity in alopecia areata: currentperspectives and a multidimensional framework. DermatolTher (Heidelb). 2022 Apr;12(4):825-834. doi: 10.1007/s13555-022-00711-3.
19. King BA, Mesinkovska NA, Craiglow B, et al. Developmentof the alopecia areata scale for clinical use: results of an academic-industry collaborative effort. J Am Acad Dermatol. 2022Feb;86(2):359–364. doi: 10.1016/j.jaad.2021.08.043.